MCMCB Pro
J1212

J1212Injection, dmso, dimethyl sulfoxide, 50%, 50 ml

HCPCSActiveBETOS O1E

J1212 is a HCPCS Level II code for injection, dmso, dimethyl sulfoxide, 50%, 50 ml. It belongs to the Drugs Administered Other Than Oral Method section. Whether Medicare pays it depends on the coverage rule below.

Medicare coverage: Special coverage instructions apply

There are published conditions attached to this code. Check the applicable coverage policy before billing it: the code being valid is not the same as the service being covered.

From the coverage field of the CMS Alpha-Numeric HCPCS File, release 2026Q3-Jul. This states Medicare’s position on the code, not on your particular claim.

Physician fee schedule statusE

Excluded from the physician fee schedule by regulation. Payment, where it exists, comes from another fee schedule (drugs via ASP, supplies via DMEPOS, and so on).

Global period: XXX

Want the dollar amount for your locality? The fee calculator applies your GPCI and the current conversion factor.

Medically Unlikely Edits — units per day

The most units of J1212 Medicare will pay on one date of service. Bill more on a single line and it is denied. The limit is not the same in every setting, so the row that matters is the one matching the claim you are building.

practitioner
1 unit
MAI 3 — Date of Service Edit: Clinical · Prescribing Information
outpatient
1 unit
MAI 3 — Date of Service Edit: Clinical · Prescribing Information
DME supplier
0 — never payable
MAI 3 — Date of Service Edit: Clinical · CMS Policy

The adjudication indicator decides whether exceeding the limit is worth appealing at all: MAI 1 is a line edit you can support with documentation, MAI 3 is a date-of-service edit that is also appealable, and MAI 2 is absolute — no documentation overrides it. CMS MUE 2026Q3.

The CMS record for J1212

Long descriptor
Injection, dmso, dimethyl sulfoxide, 50%, 50 ml

The official wording. This is what the code means.

Short descriptor
Dimethyl sulfoxide 50% 50 ml

CMS's 28-character form, which is what shows up on a remittance advice.

Added
January 1, 1986

When CMS introduced the code.

BETOS
O1E

Berenson-Eggers Type of Service — CMS's own analytic grouping.

Pricing indicator
51 — Other

Drugs.

Codes adjacent to J1212

HCPCS has no hierarchy — related items simply sit next to each other in the numbering. If J1212 is not quite right, the correct code is very often within a few positions of it.

  • J1171Injection, hydromorphone, 0.1 mg
  • J1180Injection, dyphylline, up to 500 mg
  • J1190Injection, dexrazoxane hydrochloride, per 250 mg
  • J1200Injection, diphenhydramine hcl, up to 50 mg
  • J1201Injection, cetirizine hydrochloride, 0.5 mg
  • J1202Miglustat, oral, 65 mg
  • J1203Injection, cipaglucosidase alfa-atga, 5 mg
  • J1205Injection, chlorothiazide sodium, per 500 mg
  • J1230Injection, methadone hcl, up to 10 mg
  • J1240Injection, dimenhydrinate, up to 50 mg
  • J1245Injection, dipyridamole, per 10 mg
  • J1250Injection, dobutamine hydrochloride, per 250 mg
  • J1260Injection, dolasetron mesylate, 10 mg
  • J1265Injection, dopamine hcl, 40 mg
  • J1267Injection, doripenem, 10 mgterminated
  • J1270Injection, doxercalciferol, 1 mcg

Questions about J1212

What is HCPCS code J1212?

J1212 is a HCPCS Level II code for injection, dmso, dimethyl sulfoxide, 50%, 50 ml. It sits in the Drugs Administered Other Than Oral Method section.

Does Medicare cover J1212?

The CMS HCPCS file marks J1212 as "Special coverage instructions apply". There are published conditions attached to this code. Check the applicable coverage policy before billing it: the code being valid is not the same as the service being covered.

How is J1212 paid under the physician fee schedule?

J1212 carries PFS status code E. Excluded from the physician fee schedule by regulation. Payment, where it exists, comes from another fee schedule (drugs via ASP, supplies via DMEPOS, and so on).

HCPCS Level II2026Q3-Jul· effective July 1, 2026